Immune mechanisms exacerbate the severity of hypertension in humans and animal models of disease. This review summarizes recent mechanistic studies exploring the pathways whereby immunity influences saltsensitive hypertension and renal disease.
INTRODUCTION
Multiple reports in the past half century have documented the importance of the immune system in hypertension, vascular disease, and renal disease; these studies have been the subject of multiple review articles [1 & ,2-5]. In the past 10-15 years, with the availability of new experimental tools, great progress has been made that has provided the fundamental links between immunity and cardiovascular disease. In particular, seminal studies by Harrison's group used an approach with adoptive transfer of immune cells in immune deficient mice to illustrate the role of T lymphocytes in experimental hypertension [6] . These studies have driven increased interest in this area of study.
A broad body of literature has demonstrated the participation of immunity in multiple models of hypertension in animals [1 & ], but the work in humans is less extensive. Nevertheless, data obtained from patients are consistent with observations in animal studies. It was shown in hypertensive patients that mononuclear cells infiltrate the renal interstitial spaces surrounding damaged glomeruli and tubules [7] , as well as the arterioles and small arteries of the kidney [8] . Subsequent studies demonstrated that hypertensive patients have increased renal fibrosis, glomerulosclerosis, and macrophage and T-lymphocyte infiltration in the kidney when compared with normotensive individuals [9] . There is, therefore, a clear association between the infiltration of immune cells in the kidney and hypertension and renal damage in patients; the mechanistic relationship is not well defined, although several studies indicate that the severity of hypertension can be altered in patients receiving immunomodulatory therapy [10, 11] . Moreover, genetic association studies also suggest that the immune system is important in hypertension [5] . Together, the histological, functional, and genetic data support the hypothesis that inappropriate immune activation plays a part in the development of hypertension and renal disease in humans.
IMMUNITY AND SALT-SENSITIVE HYPERTENSION IN ANIMALS AND PATIENTS
Recent work in our laboratory has explored the role of immune mechanisms in the hypertension and renal damage that occurs in Dahl salt-sensitive rats. There are strong similarities in phenotypes between salt-sensitive hypertension and renal disease in Dahl salt-sensitive rats and in humans [5] . The Dahl saltsensitive strain and selected human volunteers exhibit elevated arterial pressure when sodium intake is increased [5] . Dahl salt-sensitive rats exhibit albuminuria and renal damage that associates with sodium-sensitive hypertension; these observations are also consistent with the increased albumin excretion reported in salt-sensitive humans [5] and the renal cortical fibrosis and glomerulosclerosis that occurs in hypertensive patients [9] . Finally, both Dahl salt-sensitive fed high salt and hypertensive humans demonstrate an infiltration of macrophages and CD4 þ and CD8 þ T cells in the kidneys [5, 9] . The Dahl salt-sensitive and other rodent models appear to be useful to explore the role of immunity in salt-sensitive disease in the context of human disease.
Initial studies examined immunoreactive markers of infiltrating immune cells in the kidney of Dahl salt-sensitive fed high salt compared with age-matched rats fed low salt. Several different approaches were used to demonstrate increased infiltration of macrophages and T lymphocytes in the kidneys of Dahl salt-sensitive rats fed a high-salt diet. The infiltrating macrophages were found surrounding damaged glomeruli and in the medullary interstitial spaces near blocked renal tubules, and Tlymphocytes surrounded damaged glomeruli and tubules, as well as regions surrounding renal blood vessels [5] . In contrast, normotensive Sprague Dawley rats have negligible renal damage or increased immune cell infiltration when fed a high-salt diet, indicating that the infiltration of immune cells into the Dahl salt-sensitive kidney is related to the disease phenotype. A subsequent gene expression analysis revealed significantly greater expression of mRNA encoding inflammatory molecules associated with T cell signaling in T cells isolated from the kidney in comparison with circulating T cells [12 & ]. The increased expression of these and other factors indicates that infiltrating T cells in the kidney are activated and proliferating. The infiltrating immune cells may therefore be a source of proinflammatory cytokines, as well as angiotensin II (Ang II), free radicals, or other factors that can influence arterial blood pressure [1 ,5] . To demonstrate the importance of the infiltrating immune cells in the development of salt-sensitive hypertension and renal disease, experiments were performed in which pharmacological inhibitors of the immune system were administered to Dahl salt-sensitive rats during the period of highsalt intake. Two mechanistically different immunosuppressive agents, administered to Dahl salt-sensitive rats during the period of high-salt intake, prevented the infiltration of T cells into the kidneys of the treated animals and attenuated the development of salt-sensitive hypertension and renal damage [5] . Subsequent studies utilized zinc finger nuclease technology to delete recombination activating gene 1 (leading to a loss of mature T and B cells) and CD247 (leading to a loss of T cells) in the Dahl salt-sensitive genetic background. Experiments performed on these mutant rats demonstrated that elimination of the T cells attenuated the sodium-sensitive hypertension and renal damage in the Dahl salt-sensitive rats [12 & ,13] . These studies demonstrated the importance of T cells as amplifiers of salt-sensitive hypertension and renal damage. It has been interpreted that tissue damage, as a result of an initial increase in arterial pressure, triggers the inappropriate immune response in hypertension [5] .
To link the Dahl salt-sensitive with human disease, studies were performed to examine SH2B3, a gene linked to human hypertension and renal disease through genome wide association studies [14 && ]. SH2B3 is an intracellular adaptor protein that functions as a negative regulator in many signaling pathways, including inflammatory signaling processes. A zinc finger nuclease-mediated mutation of SH2B3, predicted to delete three amino acids in the SH2 domain, significantly attenuated the infiltration of leukocytes into the kidneys, which was accompanied by a reduction of salt-sensitive hypertension and renal disease. A separate report demonstrated that mice lacking SH2B3 have an exaggerated hypertensive response to Ang II [15 && ]. Together, these studies provide further support for the
KEY POINTS
Recent studies indicate that the activation of adaptive immune mechanisms amplifies the severity of sodiumsensitive hypertension and end-organ damage.
The activation of adaptive immunity may involve multiple factors, including the sympathetic nervous system, B cells, T cells, and sodium concentration.
The mechanism of action of these immune responses involves the release of proinflammatory cytokines and autoantibodies.
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immune system's role in the pathogenesis of hypertension and end-organ damage.
MECHANISM OF ACTION OF T LYMPHOCYTES IN HYPERTENSION
As discussed above, T lymphocytes have become a focus of multiple studies interested in the immune mechanisms of hypertension. Investigators have worked to delineate the T cell subtypes present in relevant tissues and elucidate the pathways leading to disease. Important roles for cytotoxic (CD8 þ ) T cells and T helper (Th, CD4 þ ) cells in hypertension have been established in recent studies. T helper cells are further subdivided into four main subtypes: Th1, Th2, Th17, and regulatory cells, with each subtype playing a distinct function in immune regulation. The specific contribution of these subtypes in hypertension is currently being investigated.
Recent findings have indicated deleterious roles for CD8 þ T cells in hypertension. In comparison with normotensive patients, it was shown that circulating CD8 þ T cells in hypertensive patients expressed significantly higher levels of perforin and granzyme B, two effectors of apoptosis, as well as the proinflammatory cytokines, IFNg and TNFa [16] . As described above, biopsies from patients with hypertensive renal disease reveal a significant accumulation of CD8 þ and CD4 þ T cells, in the kidney when compared with normotensive controls [9] . As a mechanistic demonstration of the importance of different T cell subtypes, it was recently demonstrated that mice deficient in CD8 þ T cells (CD8 À/À ) were protected from Ang II-induced hypertension and vascular dysfunction, whereas mice lacking CD4 þ T cells (CD4 À/À ) were not [17 & ]. Furthermore, CD8 À/À mice, but not CD4 À/À mice, were resistant to the antinatriuretic and antidiuretic effects of Ang II.
Other studies have demonstrated a role for CD4 þ T cells in the modulation of blood pressure. Transfer of CD4 þ T cells from pregnant rats with placental ischemia increased oxidative stress and blood pressure in normal pregnant recipients [18 & ]. In patients with pulmonary hypertension, circulating CD4 þ T cells expressed higher levels of IL-17 than controls, suggesting a polarization of T cells to the pathogenic Th17 phenotype [19 T cell function may also account for sex differences in experimental hypertension. Male mice develop higher blood pressure than females when infused with Ang II; an effect abolished in mice lacking T and B cells. As further proof, adoptive transfer of CD3 þ cells from male, but not female, wild type mice into male Rag1 À/À mice recapitulated Ang II-induced hypertension [21 & ]. Of interest, invitro stimulation of lymph node mononuclear cells in Th0 (no cytokines) or Th17 polarizing conditions with Ang II in-vitro led to reduced IFNg, TNFa, and IL-17 production in female but not male lymph node mononuclear cells. These data suggest important sex-dependent effects of T-cell function in hypertension.
ACTIVATION OF T LYMPHOCYTES
The contribution of T lymphocytes in the pathogenesis of hypertension has been well documented, and a number of novel mechanisms leading to T cell activation have been proposed. The importance of the central nervous system and sympathetic tone as contributing factors in human and experimental hypertension is well recognized [22, 23] . It was recently demonstrated that lesion of the anteroventral third ventricle, a region of the circumventricular organs in the brain, attenuated Ang II-induced hypertension, as well as expression of the early T-cell activation marker CD69 [24] . Increased dietary salt intake has been shown to significantly increase sympathetic nerve activity in Sprague-Dawley rats [25] . This may arise from elevated cerebrospinal fluid [Na þ ] that is detected in the circumventricular organs and results in increased sympathetic drive [26] . More recently, placental growth factor (PIGF) was shown to be required for Ang II-induced hypertension and served as a neuro-immune link between the sympathetic nervous system and the splenic immune system [27 && ]. Splenic activation of PIGF was also shown to be necessary for the costimulation of T cells which are causative players in end-organ damage in hypertension.
Therefore, it is classically believed that the major histocompatibility complex on antigen-presenting cells (APCs) presents peptides to the T cell receptor (TCR). A second signal, known as costimulation, then occurs, whereby CD28 on T cells interacts with the B7 ligands CD80 and CD86 on APCs. Both signals are required for the activation of T cells. Inhibition of B7-dependent costimulation prevented the interaction between T cells and APCs and attenuated Ang II or deoxycorticosterone acetate-salt-induced models of experimental hypertension [28] . Importantly, the inhibition of the B7/ CD28 interaction blocked T cell activation, cytokine production, and the migration of T cells to the vascular wall. Related to this observation, our laboratory recently demonstrated that a functional TCR is necessary for the full development of saltsensitive hypertension [12 & ]. Genetic deletion of the CD3 zeta chain of the TCR blunted the hypertension and accompanying renal damage associated with increased salt intake in the Dahl salt-sensitive. These studies demonstrate the necessary role of both the T cell receptor and B7/CD28 interaction in the activation of T cells that ultimately contribute to hypertension and end-organ damage.
Although the importance of T cells in hypertension is clear, recent studies have also demonstrated the importance of B cells and the production of autoantibodies in hypertension. Autoantibodies against a 1 -and and b 1 -adrenergic receptors have been shown to contribute to cardiovascular disease [29, 30] . Moreover, Ang II type 1 receptor agonistic autoantibodies (AT1-AA) are observed in patients and in rodent models of hypertension associated with preeclampsia [31] . It was demonstrated that depletion of B cells decreased cytokine production and blocked systemic lupus erythematosus (SLE)induced hypertension and renal damage in mice [32 & ]. Although adoptive transfer approaches have demonstrated that T cells are critical for the development of Ang II-induced hypertension in mice [6] , it is known that T cells produce cytokines which may modulate the function of other immune cells. Supporting this concept, the adoptive transfer of CD4 þ T cells isolated from rats subjected to the reduced uterine perfusion pressure (RUPP) model of preeclampsia increased mean arterial pressure in normal pregnant rats, but depletion of B cells inhibited the ability of CD4 þ RUPP cells to elevate blood pressure [32 & ]. In that model, the interdependency between different immune cell types is apparent.
The mechanisms triggering the adaptive immune response in hypertension are unknown. In chronic diseases such as hypertension, activation may occur through the loss of self-tolerance, suggesting that hypertension may be an autoimmune disease. Major efforts have been made to identify a self-antigen or neoantigen responsible for the initiation of adaptive immunity. It has been hypothesized that proteins modified via oxidation, nitrosylation, adduct formation, or posttranslational modifications create molecules that are no longer distinguished as self [2] . Recent studies proposed that an autoimmune reaction to heat shock protein 70 (HSP70) could lead to salt-sensitive hypertension characterized by T cell activation and the production of regulatory T cells [33] . Tolerization and overexpression studies demonstrated that HSP70 could serve as an antigen mediating the activation of T cells and development of hypertension. More recently, it has been shown that Ang II or deoxycorticosterone acetate-salt-induced reactive oxygen species formation in dendritic cells leads to the production of isoketal adducts via lipid peroxidation. These isoketal-modified proteins activate dendritic cells; moreover, scavenging of isoketals by 2-hydroxybenzylamine prevented the immunoreactivity normally leading to Ang II-induced hypertension [34 && ]. Of interest, activated dendritic cells from Ang II-treated mice induced activation, proliferation, and cytokine production by T cells, and were shown to elicit hypertension in cell transfer studies. Together, these pioneering studies uncovered new pathways explaining potential mechanisms leading to autoimmunity and the subsequent development of hypertension and associated renal damage.
SODIUM-DEPENDENT ACTIVATION OF T LYMPHOCYTES
Recent advances have provided an insight into the mechanisms contributing to immune activation in sodium-sensitive hypertension. It was shown that there is a dramatic induction of Th17 polarization in naïve T cells when exposed to elevated sodium concentration [35, 36] . The inhibition of serumand glucocorticoid-inducible kinase-1, an enzyme induced by sodium, prevented the differentiation to the Th17 phenotype, suggesting a mechanistic pathway that could be therapeutically targeted to prevent salt-induced autoimmunity. The link between salt intake, SGK-1, and Th17 polarization has recently been reviewed [37 & ]. A longitudinal study that investigated the effects of long-term salt-intake reduction on immune status in humans demonstrated a reduction in the number of total monocytes that correlated significantly with a reduction of sodium intake. No significant differences were detected in circulating lymphocyte numbers, but IL-6 and IL-23 decreased with reduced salt intake, whereas IL-10 increased [38 & ]. These studies indicate that there is a potential relationship between dietary sodium intake, cytokine production, and immune status.
CONCLUSION
Numerous studies performed in the past 50 years have established a role for the immune system in the development of hypertension and end-organ damage. Though the mechanisms leading to activation of the immune system and the subsequent amplification of the disease process are still unresolved, studies are progressing towards a better understanding of the cell types involved in the response, the stimuli responsible for the activation of the different immune cell subtypes, and the cytokines and other factors mediating the pathogenic effects. As this field progresses, further advances should permit the development of targeted therapies to more effectively treat salt-sensitive hypertension and associated end-organ damage.
A hypothetical sequence of events, based upon the data presented in this brief review, is indicated in Fig. 1 . The data indicate that the inappropriate infiltration and activation of the immune system in salt-sensitive hypertension occurs in response to an initial stimulus, which has been proposed to be an elevation in arterial blood pressure, increased sympathetic nerve activity, or even increased sodium intake. This stimulus results in tissue damage, antigen or neoantigen formation, or the release of chemokines, free radicals, or other molecules that stimulate the infiltration and activation of immune cells into the target tissue. The infiltrated immune cells may then release free radicals, cytokines, or other factors that mediate vasoconstriction, renal sodium retention, or tissue damage that promote hypertension and endorgan damage. 
